- MedaPhor, the intelligent ultrasound software and simulation company, has confirmed it is trading in line with management's expectations.

Chairman Riccardo Pigliucci said research and development work being undertaken by the clinical division is progressing well and simulation division sales in the UK and mainland Europe are showing good signs of recovery.

Initial orders placed in key territories for the recently launched BodyWorks point of care and emergency medicine simulator are also encouraging, he added.

At 9:05am: [LON:MED] Medaphor Group Plc share price was 0p at 8.5p

Story provided by